Raymond Mak MD is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation, Thoracic Radiation Oncology Disease Site Leader, and Director of Patient Safety/Quality in the Department of Radiation Oncology at BWH/DFCI. Dr. Mak is a graduate of Cornell University and Harvard Medical School, and completed his residency training in the Harvard Radiation Oncology Residency Program.

His main research interests are to develop clinically-relevant biomarkers of both tumor response and radiation-induced toxicity after radiation therapy in lung cancer using AI and novel imaging technologies, and clinical application of AI solutions to improve the quality and effectiveness of cancer therapy through the design and implantation of clinical trials. His work has been recognized with funding from NCI (U01: Site PI), and the Radiological Society of North America.